Wong说：这些品质对企业家来说同等重要。我们开始看到更加成熟、更加多样的申请。

Still, finishing lines are still quite far for Asian entrepreneurs, he said.

尽管如此，他说，对亚洲企业家来说，还有很长的路要走。

'In Asia, we have less experience and entrepreneurial depth compared with Silicon Valley, so this will take time,' he said.

他说，亚洲的经验和创业深度都不如硅谷，所以这需要时间。

While some applicants deal with health-care issues that are closely tied to socioeconomic conditions specific to their countries, Singapore-based Clearbridge BioMedics Pte., whose entry won the Gold Prize as well as the Technopreneur of the Year award, is contributing to world-wide efforts to detect and fight cancer.

一些申请者研究的是与其所在国家的具体社会经济状况密切相关的问题，而新加坡的Clearbridge BioMedics Pte.则为世界范围的癌症检测及抗癌努力做出贡献。该公司赢得了金奖及年度科技企业奖。

Clearbridge said it is developing a way to isolate circulating tumor cells -- stodgy cancer cells that spill out of the malignant tumor and flow into the bloodstream -- using a biochip that it says will physically trap such cells with its microscopic structure.

Clearbridge说，该公司正在开发一种用生物芯片分离循环肿瘤细胞的方法。循环肿瘤细胞指的是扩散至恶性肿瘤病灶以外，进入血液的顽固癌细胞。该公司说，生物芯片将利用其显微结构捕获这类癌细胞。

【癌细胞检测技术摘得“亚洲创新奖”金奖】相关文章：

★ 为企业再创信贷繁荣

★ 美投资机构担忧“财政悬崖”

★ 滑雪度假屋兴起现代化风潮

★ 香港调查南丫岛撞船事故原因

★ 韩国男性变脂粉男 去年护肤花5亿美元

★ 美多家银行同意支付抵押贷款索赔

★ 加媒抱怨“亚洲学生太多” 亚裔表示强烈不满

★ 双语：未来“台湾塔”

★ 奥运篮球运动员将被“随位安保”

★ Genomatica获本报创新奖材料类奖项